Limitations of the Unified Multiple System Atrophy Rating Scale as outcome measure for clinical trials and a roadmap for improvement is a research paper published in Clinical Autonomic Research (2021). On theSindex it has a DataRank of 1.4. It has been cited 41 times, with 26 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.561
From this paper's citation signal
Citation Network Contribution
0.814
From 17 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 26 citers.
National Institute of Neurological Disorders and Stroke
Grant: U54NS065736
National Institute of Neurological Disorders and Stroke
Grant: R01NS107596
NHLBI NIH HHS
Grant: R01 HL149386
National Institutes of Health
Grant: 3U54NS065736-02S1
Autonomic Rare Diseases Clinical Research Consortium
National Institutes of Health
Grant: 5R01NS107596-02
A futility trial of sirolimus in multiple system atrophy
Multiple System Atrophy Coalition
FWCI
2.80
Citation Percentile
0.9%
Influential Citations
3
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of Longitudinal evolution of motor and non-motor symptoms in early-stage multiple system atrophy: a 2-year prospective cohort study
Additional file 1 of Longitudinal evolution of motor and non-motor symptoms in early-stage multiple system atrophy: a 2-year prospective cohort study